Global Leishmaniasis Treatment Market Growth (Status and Outlook) 2025-2031

September 2025 | 89 pages | ID: G5E3693A2B4EN
LP Information

Abstracts

According to this study, the global Leishmaniasis Treatment market size will reach US$ 149 million by 2031.

A drug used to treat diseases caused by parasitic protozoa leishmania

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

LPI (LP Information)' newest research report, the “Leishmaniasis Treatment Industry Forecast” looks at past sales and reviews total world Leishmaniasis Treatment sales in 2024, providing a comprehensive analysis by region and market sector of projected Leishmaniasis Treatment sales for 2025 through 2031. With Leishmaniasis Treatment sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Leishmaniasis Treatment industry.

This Insight Report provides a comprehensive analysis of the global Leishmaniasis Treatment landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Leishmaniasis Treatment portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Leishmaniasis Treatment market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Leishmaniasis Treatment and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Leishmaniasis Treatment.

This report presents a comprehensive overview, market shares, and growth opportunities of Leishmaniasis Treatment market by product type, application, key players and key regions and countries.

Segmentation by Type:

• Meglumine Antimoniate
• Pentamidine
• Hydroxyl Amidine Stilbene
• Amphotericin B

Segmentation by Application:

• Visceral Leishmaniasis
• Cutaneous Leishmaniasis

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Merck
• iCo Therapeutics
• AEterna Zentaris
• AEterna Zentaris AG
• Eurofins Advinus
• Pieris Pharmaceuticals
• Dafra Pharma

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Leishmaniasis Treatment Market Size (2020-2031)
  2.1.2 Leishmaniasis Treatment Market Size CAGR by Region (2020 VS 2024 VS 2031)
  2.1.3 World Current & Future Analysis for Leishmaniasis Treatment by Country/Region (2020, 2024 & 2031)
2.2 Leishmaniasis Treatment Segment by Type
  2.2.1 Meglumine Antimoniate
  2.2.2 Pentamidine
  2.2.3 Hydroxyl Amidine Stilbene
  2.2.4 Amphotericin B
2.3 Leishmaniasis Treatment Market Size by Type
  2.3.1 Leishmaniasis Treatment Market Size CAGR by Type (2020 VS 2024 VS 2031)
  2.3.2 Global Leishmaniasis Treatment Market Size Market Share by Type (2020-2025)
2.4 Leishmaniasis Treatment Segment by Application
  2.4.1 Visceral Leishmaniasis
  2.4.2 Cutaneous Leishmaniasis
2.5 Leishmaniasis Treatment Market Size by Application
  2.5.1 Leishmaniasis Treatment Market Size CAGR by Application (2020 VS 2024 VS 2031)
  2.5.2 Global Leishmaniasis Treatment Market Size Market Share by Application (2020-2025)

3 LEISHMANIASIS TREATMENT MARKET SIZE BY PLAYER

3.1 Leishmaniasis Treatment Market Size Market Share by Player
  3.1.1 Global Leishmaniasis Treatment Revenue by Player (2020-2025)
  3.1.2 Global Leishmaniasis Treatment Revenue Market Share by Player (2020-2025)
3.2 Global Leishmaniasis Treatment Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 LEISHMANIASIS TREATMENT BY REGION

4.1 Leishmaniasis Treatment Market Size by Region (2020-2025)
4.2 Global Leishmaniasis Treatment Annual Revenue by Country/Region (2020-2025)
4.3 Americas Leishmaniasis Treatment Market Size Growth (2020-2025)
4.4 APAC Leishmaniasis Treatment Market Size Growth (2020-2025)
4.5 Europe Leishmaniasis Treatment Market Size Growth (2020-2025)
4.6 Middle East & Africa Leishmaniasis Treatment Market Size Growth (2020-2025)

5 AMERICAS

5.1 Americas Leishmaniasis Treatment Market Size by Country (2020-2025)
5.2 Americas Leishmaniasis Treatment Market Size by Type (2020-2025)
5.3 Americas Leishmaniasis Treatment Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Leishmaniasis Treatment Market Size by Region (2020-2025)
6.2 APAC Leishmaniasis Treatment Market Size by Type (2020-2025)
6.3 APAC Leishmaniasis Treatment Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Leishmaniasis Treatment Market Size by Country (2020-2025)
7.2 Europe Leishmaniasis Treatment Market Size by Type (2020-2025)
7.3 Europe Leishmaniasis Treatment Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Leishmaniasis Treatment by Region (2020-2025)
8.2 Middle East & Africa Leishmaniasis Treatment Market Size by Type (2020-2025)
8.3 Middle East & Africa Leishmaniasis Treatment Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL LEISHMANIASIS TREATMENT MARKET FORECAST

10.1 Global Leishmaniasis Treatment Forecast by Region (2026-2031)
  10.1.1 Global Leishmaniasis Treatment Forecast by Region (2026-2031)
  10.1.2 Americas Leishmaniasis Treatment Forecast
  10.1.3 APAC Leishmaniasis Treatment Forecast
  10.1.4 Europe Leishmaniasis Treatment Forecast
  10.1.5 Middle East & Africa Leishmaniasis Treatment Forecast
10.2 Americas Leishmaniasis Treatment Forecast by Country (2026-2031)
  10.2.1 United States Market Leishmaniasis Treatment Forecast
  10.2.2 Canada Market Leishmaniasis Treatment Forecast
  10.2.3 Mexico Market Leishmaniasis Treatment Forecast
  10.2.4 Brazil Market Leishmaniasis Treatment Forecast
10.3 APAC Leishmaniasis Treatment Forecast by Region (2026-2031)
  10.3.1 China Leishmaniasis Treatment Market Forecast
  10.3.2 Japan Market Leishmaniasis Treatment Forecast
  10.3.3 Korea Market Leishmaniasis Treatment Forecast
  10.3.4 Southeast Asia Market Leishmaniasis Treatment Forecast
  10.3.5 India Market Leishmaniasis Treatment Forecast
  10.3.6 Australia Market Leishmaniasis Treatment Forecast
10.4 Europe Leishmaniasis Treatment Forecast by Country (2026-2031)
  10.4.1 Germany Market Leishmaniasis Treatment Forecast
  10.4.2 France Market Leishmaniasis Treatment Forecast
  10.4.3 UK Market Leishmaniasis Treatment Forecast
  10.4.4 Italy Market Leishmaniasis Treatment Forecast
  10.4.5 Russia Market Leishmaniasis Treatment Forecast
10.5 Middle East & Africa Leishmaniasis Treatment Forecast by Region (2026-2031)
  10.5.1 Egypt Market Leishmaniasis Treatment Forecast
  10.5.2 South Africa Market Leishmaniasis Treatment Forecast
  10.5.3 Israel Market Leishmaniasis Treatment Forecast
  10.5.4 Turkey Market Leishmaniasis Treatment Forecast
10.6 Global Leishmaniasis Treatment Forecast by Type (2026-2031)
10.7 Global Leishmaniasis Treatment Forecast by Application (2026-2031)
  10.7.1 GCC Countries Market Leishmaniasis Treatment Forecast

11 KEY PLAYERS ANALYSIS

11.1 Merck
  11.1.1 Merck Company Information
  11.1.2 Merck Leishmaniasis Treatment Product Offered
  11.1.3 Merck Leishmaniasis Treatment Revenue, Gross Margin and Market Share (2020-2025)
  11.1.4 Merck Main Business Overview
  11.1.5 Merck Latest Developments
11.2 iCo Therapeutics
  11.2.1 iCo Therapeutics Company Information
  11.2.2 iCo Therapeutics Leishmaniasis Treatment Product Offered
  11.2.3 iCo Therapeutics Leishmaniasis Treatment Revenue, Gross Margin and Market Share (2020-2025)
  11.2.4 iCo Therapeutics Main Business Overview
  11.2.5 iCo Therapeutics Latest Developments
11.3 AEterna Zentaris
  11.3.1 AEterna Zentaris Company Information
  11.3.2 AEterna Zentaris Leishmaniasis Treatment Product Offered
  11.3.3 AEterna Zentaris Leishmaniasis Treatment Revenue, Gross Margin and Market Share (2020-2025)
  11.3.4 AEterna Zentaris Main Business Overview
  11.3.5 AEterna Zentaris Latest Developments
11.4 AEterna Zentaris AG
  11.4.1 AEterna Zentaris AG Company Information
  11.4.2 AEterna Zentaris AG Leishmaniasis Treatment Product Offered
  11.4.3 AEterna Zentaris AG Leishmaniasis Treatment Revenue, Gross Margin and Market Share (2020-2025)
  11.4.4 AEterna Zentaris AG Main Business Overview
  11.4.5 AEterna Zentaris AG Latest Developments
11.5 Eurofins Advinus
  11.5.1 Eurofins Advinus Company Information
  11.5.2 Eurofins Advinus Leishmaniasis Treatment Product Offered
  11.5.3 Eurofins Advinus Leishmaniasis Treatment Revenue, Gross Margin and Market Share (2020-2025)
  11.5.4 Eurofins Advinus Main Business Overview
  11.5.5 Eurofins Advinus Latest Developments
11.6 Pieris Pharmaceuticals
  11.6.1 Pieris Pharmaceuticals Company Information
  11.6.2 Pieris Pharmaceuticals Leishmaniasis Treatment Product Offered
  11.6.3 Pieris Pharmaceuticals Leishmaniasis Treatment Revenue, Gross Margin and Market Share (2020-2025)
  11.6.4 Pieris Pharmaceuticals Main Business Overview
  11.6.5 Pieris Pharmaceuticals Latest Developments
11.7 Dafra Pharma
  11.7.1 Dafra Pharma Company Information
  11.7.2 Dafra Pharma Leishmaniasis Treatment Product Offered
  11.7.3 Dafra Pharma Leishmaniasis Treatment Revenue, Gross Margin and Market Share (2020-2025)
  11.7.4 Dafra Pharma Main Business Overview
  11.7.5 Dafra Pharma Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Leishmaniasis Treatment Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Leishmaniasis Treatment Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Meglumine Antimoniate
Table 4. Major Players of Pentamidine
Table 5. Major Players of Hydroxyl Amidine Stilbene
Table 6. Major Players of Amphotericin B
Table 7. Leishmaniasis Treatment Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 8. Global Leishmaniasis Treatment Market Size by Type (2020-2025) & ($ millions)
Table 9. Global Leishmaniasis Treatment Market Size Market Share by Type (2020-2025)
Table 10. Leishmaniasis Treatment Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 11. Global Leishmaniasis Treatment Market Size by Application (2020-2025) & ($ millions)
Table 12. Global Leishmaniasis Treatment Market Size Market Share by Application (2020-2025)
Table 13. Global Leishmaniasis Treatment Revenue by Player (2020-2025) & ($ millions)
Table 14. Global Leishmaniasis Treatment Revenue Market Share by Player (2020-2025)
Table 15. Leishmaniasis Treatment Key Players Head office and Products Offered
Table 16. Leishmaniasis Treatment Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global Leishmaniasis Treatment Market Size by Region (2020-2025) & ($ millions)
Table 20. Global Leishmaniasis Treatment Market Size Market Share by Region (2020-2025)
Table 21. Global Leishmaniasis Treatment Revenue by Country/Region (2020-2025) & ($ millions)
Table 22. Global Leishmaniasis Treatment Revenue Market Share by Country/Region (2020-2025)
Table 23. Americas Leishmaniasis Treatment Market Size by Country (2020-2025) & ($ millions)
Table 24. Americas Leishmaniasis Treatment Market Size Market Share by Country (2020-2025)
Table 25. Americas Leishmaniasis Treatment Market Size by Type (2020-2025) & ($ millions)
Table 26. Americas Leishmaniasis Treatment Market Size Market Share by Type (2020-2025)
Table 27. Americas Leishmaniasis Treatment Market Size by Application (2020-2025) & ($ millions)
Table 28. Americas Leishmaniasis Treatment Market Size Market Share by Application (2020-2025)
Table 29. APAC Leishmaniasis Treatment Market Size by Region (2020-2025) & ($ millions)
Table 30. APAC Leishmaniasis Treatment Market Size Market Share by Region (2020-2025)
Table 31. APAC Leishmaniasis Treatment Market Size by Type (2020-2025) & ($ millions)
Table 32. APAC Leishmaniasis Treatment Market Size by Application (2020-2025) & ($ millions)
Table 33. Europe Leishmaniasis Treatment Market Size by Country (2020-2025) & ($ millions)
Table 34. Europe Leishmaniasis Treatment Market Size Market Share by Country (2020-2025)
Table 35. Europe Leishmaniasis Treatment Market Size by Type (2020-2025) & ($ millions)
Table 36. Europe Leishmaniasis Treatment Market Size by Application (2020-2025) & ($ millions)
Table 37. Middle East & Africa Leishmaniasis Treatment Market Size by Region (2020-2025) & ($ millions)
Table 38. Middle East & Africa Leishmaniasis Treatment Market Size by Type (2020-2025) & ($ millions)
Table 39. Middle East & Africa Leishmaniasis Treatment Market Size by Application (2020-2025) & ($ millions)
Table 40. Key Market Drivers & Growth Opportunities of Leishmaniasis Treatment
Table 41. Key Market Challenges & Risks of Leishmaniasis Treatment
Table 42. Key Industry Trends of Leishmaniasis Treatment
Table 43. Global Leishmaniasis Treatment Market Size Forecast by Region (2026-2031) & ($ millions)
Table 44. Global Leishmaniasis Treatment Market Size Market Share Forecast by Region (2026-2031)
Table 45. Global Leishmaniasis Treatment Market Size Forecast by Type (2026-2031) & ($ millions)
Table 46. Global Leishmaniasis Treatment Market Size Forecast by Application (2026-2031) & ($ millions)
Table 47. Merck Details, Company Type, Leishmaniasis Treatment Area Served and Its Competitors
Table 48. Merck Leishmaniasis Treatment Product Offered
Table 49. Merck Leishmaniasis Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 50. Merck Main Business
Table 51. Merck Latest Developments
Table 52. iCo Therapeutics Details, Company Type, Leishmaniasis Treatment Area Served and Its Competitors
Table 53. iCo Therapeutics Leishmaniasis Treatment Product Offered
Table 54. iCo Therapeutics Leishmaniasis Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 55. iCo Therapeutics Main Business
Table 56. iCo Therapeutics Latest Developments
Table 57. AEterna Zentaris Details, Company Type, Leishmaniasis Treatment Area Served and Its Competitors
Table 58. AEterna Zentaris Leishmaniasis Treatment Product Offered
Table 59. AEterna Zentaris Leishmaniasis Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 60. AEterna Zentaris Main Business
Table 61. AEterna Zentaris Latest Developments
Table 62. AEterna Zentaris AG Details, Company Type, Leishmaniasis Treatment Area Served and Its Competitors
Table 63. AEterna Zentaris AG Leishmaniasis Treatment Product Offered
Table 64. AEterna Zentaris AG Leishmaniasis Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 65. AEterna Zentaris AG Main Business
Table 66. AEterna Zentaris AG Latest Developments
Table 67. Eurofins Advinus Details, Company Type, Leishmaniasis Treatment Area Served and Its Competitors
Table 68. Eurofins Advinus Leishmaniasis Treatment Product Offered
Table 69. Eurofins Advinus Leishmaniasis Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 70. Eurofins Advinus Main Business
Table 71. Eurofins Advinus Latest Developments
Table 72. Pieris Pharmaceuticals Details, Company Type, Leishmaniasis Treatment Area Served and Its Competitors
Table 73. Pieris Pharmaceuticals Leishmaniasis Treatment Product Offered
Table 74. Pieris Pharmaceuticals Leishmaniasis Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 75. Pieris Pharmaceuticals Main Business
Table 76. Pieris Pharmaceuticals Latest Developments
Table 77. Dafra Pharma Details, Company Type, Leishmaniasis Treatment Area Served and Its Competitors
Table 78. Dafra Pharma Leishmaniasis Treatment Product Offered
Table 79. Dafra Pharma Leishmaniasis Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 80. Dafra Pharma Main Business
Table 81. Dafra Pharma Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Leishmaniasis Treatment Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Leishmaniasis Treatment Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Leishmaniasis Treatment Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Leishmaniasis Treatment Sales Market Share by Country/Region (2024)
Figure 8. Leishmaniasis Treatment Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Leishmaniasis Treatment Market Size Market Share by Type in 2024
Figure 10. Leishmaniasis Treatment in Visceral Leishmaniasis
Figure 11. Global Leishmaniasis Treatment Market: Visceral Leishmaniasis (2020-2025) & ($ millions)
Figure 12. Leishmaniasis Treatment in Cutaneous Leishmaniasis
Figure 13. Global Leishmaniasis Treatment Market: Cutaneous Leishmaniasis (2020-2025) & ($ millions)
Figure 14. Global Leishmaniasis Treatment Market Size Market Share by Application in 2024
Figure 15. Global Leishmaniasis Treatment Revenue Market Share by Player in 2024
Figure 16. Global Leishmaniasis Treatment Market Size Market Share by Region (2020-2025)
Figure 17. Americas Leishmaniasis Treatment Market Size 2020-2025 ($ millions)
Figure 18. APAC Leishmaniasis Treatment Market Size 2020-2025 ($ millions)
Figure 19. Europe Leishmaniasis Treatment Market Size 2020-2025 ($ millions)
Figure 20. Middle East & Africa Leishmaniasis Treatment Market Size 2020-2025 ($ millions)
Figure 21. Americas Leishmaniasis Treatment Value Market Share by Country in 2024
Figure 22. United States Leishmaniasis Treatment Market Size Growth 2020-2025 ($ millions)
Figure 23. Canada Leishmaniasis Treatment Market Size Growth 2020-2025 ($ millions)
Figure 24. Mexico Leishmaniasis Treatment Market Size Growth 2020-2025 ($ millions)
Figure 25. Brazil Leishmaniasis Treatment Market Size Growth 2020-2025 ($ millions)
Figure 26. APAC Leishmaniasis Treatment Market Size Market Share by Region in 2024
Figure 27. APAC Leishmaniasis Treatment Market Size Market Share by Type (2020-2025)
Figure 28. APAC Leishmaniasis Treatment Market Size Market Share by Application (2020-2025)
Figure 29. China Leishmaniasis Treatment Market Size Growth 2020-2025 ($ millions)
Figure 30. Japan Leishmaniasis Treatment Market Size Growth 2020-2025 ($ millions)
Figure 31. South Korea Leishmaniasis Treatment Market Size Growth 2020-2025 ($ millions)
Figure 32. Southeast Asia Leishmaniasis Treatment Market Size Growth 2020-2025 ($ millions)
Figure 33. India Leishmaniasis Treatment Market Size Growth 2020-2025 ($ millions)
Figure 34. Australia Leishmaniasis Treatment Market Size Growth 2020-2025 ($ millions)
Figure 35. Europe Leishmaniasis Treatment Market Size Market Share by Country in 2024
Figure 36. Europe Leishmaniasis Treatment Market Size Market Share by Type (2020-2025)
Figure 37. Europe Leishmaniasis Treatment Market Size Market Share by Application (2020-2025)
Figure 38. Germany Leishmaniasis Treatment Market Size Growth 2020-2025 ($ millions)
Figure 39. France Leishmaniasis Treatment Market Size Growth 2020-2025 ($ millions)
Figure 40. UK Leishmaniasis Treatment Market Size Growth 2020-2025 ($ millions)
Figure 41. Italy Leishmaniasis Treatment Market Size Growth 2020-2025 ($ millions)
Figure 42. Russia Leishmaniasis Treatment Market Size Growth 2020-2025 ($ millions)
Figure 43. Middle East & Africa Leishmaniasis Treatment Market Size Market Share by Region (2020-2025)
Figure 44. Middle East & Africa Leishmaniasis Treatment Market Size Market Share by Type (2020-2025)
Figure 45. Middle East & Africa Leishmaniasis Treatment Market Size Market Share by Application (2020-2025)
Figure 46. Egypt Leishmaniasis Treatment Market Size Growth 2020-2025 ($ millions)
Figure 47. South Africa Leishmaniasis Treatment Market Size Growth 2020-2025 ($ millions)
Figure 48. Israel Leishmaniasis Treatment Market Size Growth 2020-2025 ($ millions)
Figure 49. Turkey Leishmaniasis Treatment Market Size Growth 2020-2025 ($ millions)
Figure 50. GCC Countries Leishmaniasis Treatment Market Size Growth 2020-2025 ($ millions)
Figure 51. Americas Leishmaniasis Treatment Market Size 2026-2031 ($ millions)
Figure 52. APAC Leishmaniasis Treatment Market Size 2026-2031 ($ millions)
Figure 53. Europe Leishmaniasis Treatment Market Size 2026-2031 ($ millions)
Figure 54. Middle East & Africa Leishmaniasis Treatment Market Size 2026-2031 ($ millions)
Figure 55. United States Leishmaniasis Treatment Market Size 2026-2031 ($ millions)
Figure 56. Canada Leishmaniasis Treatment Market Size 2026-2031 ($ millions)
Figure 57. Mexico Leishmaniasis Treatment Market Size 2026-2031 ($ millions)
Figure 58. Brazil Leishmaniasis Treatment Market Size 2026-2031 ($ millions)
Figure 59. China Leishmaniasis Treatment Market Size 2026-2031 ($ millions)
Figure 60. Japan Leishmaniasis Treatment Market Size 2026-2031 ($ millions)
Figure 61. Korea Leishmaniasis Treatment Market Size 2026-2031 ($ millions)
Figure 62. Southeast Asia Leishmaniasis Treatment Market Size 2026-2031 ($ millions)
Figure 63. India Leishmaniasis Treatment Market Size 2026-2031 ($ millions)
Figure 64. Australia Leishmaniasis Treatment Market Size 2026-2031 ($ millions)
Figure 65. Germany Leishmaniasis Treatment Market Size 2026-2031 ($ millions)
Figure 66. France Leishmaniasis Treatment Market Size 2026-2031 ($ millions)
Figure 67. UK Leishmaniasis Treatment Market Size 2026-2031 ($ millions)
Figure 68. Italy Leishmaniasis Treatment Market Size 2026-2031 ($ millions)
Figure 69. Russia Leishmaniasis Treatment Market Size 2026-2031 ($ millions)
Figure 70. Egypt Leishmaniasis Treatment Market Size 2026-2031 ($ millions)
Figure 71. South Africa Leishmaniasis Treatment Market Size 2026-2031 ($ millions)
Figure 72. Israel Leishmaniasis Treatment Market Size 2026-2031 ($ millions)
Figure 73. Turkey Leishmaniasis Treatment Market Size 2026-2031 ($ millions)
Figure 74. Global Leishmaniasis Treatment Market Size Market Share Forecast by Type (2026-2031)
Figure 75. Global Leishmaniasis Treatment Market Size Market Share Forecast by Application (2026-2031)
Figure 76. GCC Countries Leishmaniasis Treatment Market Size 2026-2031 ($ millions)